SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044445
Filing Date
2021-08-16
Accepted
2021-08-16 07:23:39
Documents
55
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-10q_20210630.htm   iXBRL 10-Q 1645740
2 EX-31.1 cogt-ex311_8.htm EX-31.1 9994
3 EX-31.2 cogt-ex312_9.htm EX-31.2 9967
4 EX-32.1 cogt-ex321_6.htm EX-32.1 5972
5 EX-32.2 cogt-ex322_7.htm EX-32.2 5937
  Complete submission text file 0001564590-21-044445.txt   5819796

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cogt-20210630.xsd EX-101.SCH 45735
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cogt-20210630_cal.xml EX-101.CAL 42045
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cogt-20210630_def.xml EX-101.DEF 180712
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20210630_lab.xml EX-101.LAB 362856
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20210630_pre.xml EX-101.PRE 278931
11 EXTRACTED XBRL INSTANCE DOCUMENT cogt-10q_20210630_htm.xml XML 863380
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 211174496
SIC: 2834 Pharmaceutical Preparations